Next Article in Journal
Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers
Next Article in Special Issue
Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing
Previous Article in Journal
A Peptide Inhibitor of the Human Cytomegalovirus Core Nuclear Egress Complex
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(9), 1038; https://doi.org/10.3390/ph15091038
Action Date Notes Link
article xml file uploaded 23 August 2022 15:44 CEST Original file -
article xml uploaded. 23 August 2022 15:44 CEST Update https://www.mdpi.com/1424-8247/15/9/1038/xml
article pdf uploaded. 23 August 2022 15:44 CEST Version of Record https://www.mdpi.com/1424-8247/15/9/1038/pdf
article supplementary file uploaded. 23 August 2022 15:44 CEST - https://www.mdpi.com/1424-8247/15/9/1038#supplementary
article html file updated 23 August 2022 15:46 CEST Original file -
article html file updated 24 August 2022 21:33 CEST Update https://www.mdpi.com/1424-8247/15/9/1038/html
Back to TopTop